It has been well-established that various dysregulated signaling pathways can activate the NF-κB signaling pathway in ovarian cancer, which in turn promotes chemoresistance, cancer stem cell maintenance, metastasis, and immune evasion [29,30,31]. This evidence concerns the gene NFKB1 and ovarian cancer.